- Anzabi, Y. and Shaghaghi, S. (2015). In vitro evaluation of antibacterial properties of propolis alcoholic extract on bovine mastitis isolates. Veterinary Clinical Pathology, 9(34): 117-129. [In Persian]
- Badiei, A., Aurang A., Ali Reza, B. and Mohsen Z. (2008). The effect of general injection of three drugs, Tylosin, Enrofloxacin and penicillin-streptomycin combination on the incidence of breast swellings in newborn dairy cows, 15th Iranian Veterinary Congress, Tehran, Iranian Veterinary Society. [In Persian]
- Boonyayatra, S., Fox, L.K., Besser, T.E., Sawant, A. and Gay, J.M. (2010). Effects of storage methods on the recovery of Mycoplasma species from milk samples. Veterinary Microbiology, 144(1-2): 210-213.
- Dosogne, H., Meyer, E., Sturk, A., Van Loon, J., Massart-Leën, A.M. and Burvenich, C. (2002). Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis. Inflammation Research, 51(4): 201-205.
- Erskine, R.J., Wagner, S. and DeGraves, F.J. (2003). Mastitis therapy and pharmacology. The Veterinary clinics of North America. Food Animal Practice, 19(1): 109-138.
- Fang, W. and Pyörälä, S. (1996). Mastitis-causing Escherichia coli: serum sensitivity and susceptibility to selected antibacterials in milk. Journal of Dairy Science, 79(1): 76-82.
- Grandemange, E. (2002). Field evaluation of the efficacy of marbofloxacin in the treatment of acute mastitis due to Gram-negative bacteria in the dairy cow. Cattle Practice, 10(1): 57-62.
- Grandemange, E., Perrin, P.A., Schwab-Richards, R. and Woehrle, F. (2017). Efficacy of a single injection of marbofloxacin in the treatment of acute E. coli mastitis in lactating dairy cows. Revue de Medecine Veterinaire, 168(10-12): 219-228.
- Halasa, T., Huijps, K., Østerås, O. and Hogeveen, H. (2007). Economic effects of bovine mastitis and mastitis management: a review. Veterinary Quarterly, 29(1): 18-31.
- Hossieni Nejad, M. and Mashak, Z. (2016). Effects of somatic cell count in subclinical mastitis on raw milk quality in dairy farms of khuzestan province. Veterinary Clinical Pathology. 9(36): 335-345. [In Persian]
- House, S.A., Gadomski, A.M. and Ralston, S.L. (2020). Evaluating the placebo status of nebulized normal saline in patients with acute viral bronchiolitis: a systematic review and meta-analysis. JAMA Pediatrics, 174(3): 250-259.
- Kaartinen, L., Salonen, M., Älli, L. and Pyörälä, S. (1995). Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. Journal of Veterinary Pharmacology and Therapeutics, 18(5): 336-357.
- Kietzmann, M., Braun, M., Schneider, M. and Pankow, R. (2008). Tissue distribution of marbofloxacin after ‘systemic’administration into the isolated perfused bovine udder. The Veterinary Journal, 178(1): 115-118.
- Kroemer, S., Galland, D., Guérin-Faublée, V., Giboin, H. and Woehrlé-Fontaine, F. (2011). Survey of marbofloxacin susceptibility of bacteria isolated from cattle with respiratory disease and mastitis in Europe. Veterinary Record, 70(2): 53-53.
- Meunier, D.D., Acar, J.F., Martel, J.L., Kroemer, S. and Valle, M. (2004). Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries. International Journal of Antimicrobial Agents, 24(3): 268-278.
- Poutrel, B., Stegemann, M.R., Roy, O., Pothier, F., Tilt, N. and Payne-Johnson, M. (2008). Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. Journal of Dairy Research, 75(3): 310-318.
- Rantala, M., Kaartinen, L., Valimaki, E., Stryrman, M., Hiekkaranta, M., Niemi, A., et al. (2002). Efficacy and pharmacokinetics of enrofloxacin and flunixinmeglumine for treatment of cows with experimentally induced Escherichia coli mastitis. Journal of Veterinary Pharmacology and Therapeutics, 25(4): 251-258.
- Roberson, J.R. (2012). Treatment of clinical mastitis. Veterinary Clinics: Food Animal Practice, 28(2): 271-288.
- Schlegelova, J., Babak, V., Klimova, E., Lukasova, J., Navratilova, P., Sustackova, A., et al. (2002). Prevalence of and resistance to antimicrobial drugs in selected microbial species isolated from bulk milk samples. Journal of Veterinary Medicine, Series B, 49(5): 216-225.
- Schneider, M., Valle, M., Woehrlé, F. and Boisrame, B. (2004). Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. Journal of Dairy Science, 87(1): 202-211
- Shem‐Tov, M., Rav‐Hon, O., Ziv, G., Lavi, E., Glickman, A. and Saran, A. (1998). Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. Journal of Veterinary Pharmacology and Therapeutics, 21(3): 209-213.
- Shokohi M., Ahmadizadeh Ch. and Kaveh A. (2018). Evaluation of bacterial causes of subclinical mastitis in dairy cattle of negine sabze makoo agro-industrial and animal husbandry complex. Veterinary Clinical Pathology, 11(44): 379-388. [In Persian]
- Suojala, L., Simojoki, H., Mustonen, K., Kaartinen, L. and Pyörälä, S. (2010). Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. Journal of Dairy Science, 93(5): 1960-1969.
- Watts, J.L. (1988). Etiological agents of bovine mastitis. Veterinary microbiology, 16(1): 41-66.
- Wenz, J.R., Barrington, G.M., Garry, F.B., McSweeney, K.D., Dinsmore, R.P., Goodell, G. et al. (2001). Bacteremia associated with naturally occurring acute coliform mastitis in dairy cows. Journal of the American Veterinary Medical Association, 219(7): 976-981.
|
